Package 70771-1514-9

Brand: lamotrigine

Generic: lamotirigine
NDC Package

Package Facts

Identity

Package NDC 70771-1514-9
Digits Only 7077115149
Product NDC 70771-1514
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1514-9)

Marketing

Marketing Status
Marketed Since 2020-05-14
Brand lamotrigine
Generic lamotirigine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c2007dd5-98b7-47e2-8354-7ce432174a48", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["850087", "850091", "900156", "900164", "1098608", "1146690"], "spl_set_id": ["ecb7a528-699f-4e51-9887-dee60456da2f"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1514-3)", "package_ndc": "70771-1514-3", "marketing_start_date": "20200514"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (70771-1514-4)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1514-2)", "package_ndc": "70771-1514-4", "marketing_start_date": "20200514"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1514-5)", "package_ndc": "70771-1514-5", "marketing_start_date": "20200514"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1514-9)", "package_ndc": "70771-1514-9", "marketing_start_date": "20200514"}], "brand_name": "Lamotrigine", "product_id": "70771-1514_c2007dd5-98b7-47e2-8354-7ce432174a48", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "70771-1514", "generic_name": "Lamotirigine", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "25 mg/1"}], "application_number": "ANDA207763", "marketing_category": "ANDA", "marketing_start_date": "20200514", "listing_expiration_date": "20261231"}